ArticleScientific reports2026
Brain tumor segmentation using dual-stream multiscale 3D-UNET with dense net and spatial attention.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research work proposes an improved approach for brain tumor segmentation using a Dual-stream multi-scale 3D-UNET network integrated with DenseNet and spatial attention mechanisms. Identifying brain tumors in multichannel Magnetic Resonance Imaging (MRI) is crucial for the diagnosis and subsequent treatment. Some of these challenges include the unpredictable nature of the tumor's appearance and the need to define the subregions of the tumor accurately. Since our objectives involve updating the segmentation models for various tumor classes to better align with the BRATS 2020 MRI standard dataset, which contains MRI scans labeled by experts, we want to focus on the seven categories, including edema, enhancing tumors, and core tumors. The proposed model employs a dual-stream approach to recognize multiple input formats simultaneously, utilizing DenseNet to extract features and apply spatial attention, thereby focusing on areas of interest within the imaging data. The model achieved remarkable Dice scores, outperforming baseline results: 99.12 for improving tumors, 99.99 for swelling, and 99.88 for core tumors. The typical Dice score was 99.99 for all models on the BRATS 2020 dataset. The results are further validated when compared with the more recent BRATS 2021 set, where the accuracies are 99.45%, 98.24%, and 99.55% for the same categories, respectively. Future efforts will focus on how to adapt the suggested model to real-time data, how to consider other forms of generalization of unsupervised learning, and how clinician feedback can be incorporated to improve the interpretability and applicability of the approach to a clinical setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.